Skip to main content
. 2023 Feb 4;129:175–180. doi: 10.1016/j.ijid.2023.01.045

Table 2.

Clinical characteristics of 205 patients with monkeypox virus infection from a hospital in Peru between July and September 2022

Characteristics
Systemic symptoms, n (%)
 Cough 7 (3.4)
 Rhinorrhea 6 (2.9)
 Sore throat 79 (38.5)
 Malaise 123 (60.0)
 Fatigue 105 (51.5)
 Back pain 77 (37.6)
 Fever 162 (79.0)
 Headache 119 (58.1)
 Chills and sweats 69 (33.8)
 Pruritus 27 (13.2)
Lymphadenopathies, n (%)
 Any lymphadenopathy 111 (54.2)
 Lymphadenopathy distribution
  Localized 98 (88.3)
  Generalized 13 (11.7)
 Lymphadenopathy by region
 Axilar 2 (1.8)
  Cervical unilateral 18 (16.2)
  Cervical bilateral 22 (19.8)
  Inguinal unilateral 34 (30.6)
  Inguinal bilateral 29 (26.1)
  Submandibular 2 (1.8)
Rash or skin lesions at consultation, n (%)
 Lesion distribution
  Localized 38 (18.6)
  Generalized 166 (81.4)
 Lesion location
  Face, head or neck 128 (62.7)
  Trunk 142 (69.3)
  Upper extremities 111 (54.4)
  Lower extremities 86 (41.9)
  Anogenital area 160 (78.0)
 Lesion morphology
  Macular 116 (56.6)
  Papular 162 (79.0)
  Vesicle 44 (21.5)
  Pustule 177 (86.3)
  Ulcer 4 (2.0)
  Crust 65 (31.7)
 Lesion pattern
  Monomorphic 31 (15.1)
  Polymorphic 174 (84.9)
 Rash as first symptom identified 94 (45.9)
Time between last sexual encounter and onset of symptoms, days (median, IQR) 7 (3 - 14)
Time between onset of systemic symptoms and appearance of skin lesions, days (median, IQR) 2 (1 - 4)
Time between onset of symptoms and accessing the healthcare facility, days (mean, SD) 6.7 ± 3.3
 Started with systemic symptoms 7.4 ± 3.2
 Started with skin lesions 5.9 ± 3.3
Had a sexual encounter while experiencing symptoms, n (%) 44 (21.5)

IQR, interquartile range.